Identification of Additional Antigenic Sites on Dane Particles and the Tubular Forms of Hepatitis B Surface Antigen

References

1. Almeida J. D. 1972; Individual morphological variations seen in Australia antigen positive sera. American Journal of Disease of Children 123:303–309
   [Google Scholar]
2. Chairez R., Hollinger F. B., Melnick J. L., Dreesman G. R. 1974; Biophysical properties of purified morphologic forms of hepatitis B antigen. Intervirology 3:129–140
   [Google Scholar]
3. Couleru O., Moulias R., Peter F., Bousquet D., German A., Loeper J. 1973; Étude ultraStrUCtUTale de 1’antigène ‘Australie’. La Nouvelle Presse Médicate 2:1633–1643
   [Google Scholar]
4. Dane D. S., Cameron C. H., Briggs M. 1970; Virus-like particles in serum of patients with Australia-antigen-associated hepatitis. Lancet i:695–698
   [Google Scholar]
5. Dreesman G. R., Hollinger F. B., Suriano J. R., Fujioka R. S., Brunschwig J. P., Melnick J. L. 1972; Biophysical and biochemical heterogeneity of purified hepatitis B antigen. Journal of Virology 10:469–476
   [Google Scholar]
6. Field A. M., Cossart Y. E. 1971; Specificity of Au antibodies. Lancet ii:91
   [Google Scholar]
7. Ginsburg A. L., Conrad M. E., Bancroft W. H., Ling C. M., Overby L. R. 1972; Prevention of endemic HAA-positive hepatitis with gamma globulin. New England Journal of Medicine 286:562–566
   [Google Scholar]
8. Hilleman M. R., Buynak E. B., Roehm R. R., Tytell A. A., Bertland A. U., Lampson G. P. 1975; Purified and inactivated human hepatitis B vaccine. American Journal of Medical Sciences 270:401–404
   [Google Scholar]
9. Holland P. V., Walsh J. H., Morrow A. G., Purcell R. H. 1969; Failure of Australia antibody to prevent post-transfusion hepatitis. Lancet ii:553–555
   [Google Scholar]
10. Krugman S., Giles J. P. 1973; Viral hepatitis type B (MS-2 strain): further observations on natural history and prevention. New England Journal of Medicine 288:775–760
    [Google Scholar]
11. Magnius L. O. 1975; Characterization of a new antigen-antibody system associated with hepatitis B. Clinical and Experimental Immunology 20:209–216
    [Google Scholar]
12. Magnius L. O., Espmark Å. 1972a; A new antigen complex co-occurring with Australia antigen. Acta Pathologica et Microbiologica Scandinavica 80B:335–337
    [Google Scholar]
13. Magnius L. O., Espmark Å. 1972b; New specificities in Australia antigen positive sera distinct from the Le Bouvier determinants. Journal of Immunology 109:1017–1021
    [Google Scholar]
14. Magnius L. O., Lindholm A., Lundin P., Iwarson S. 1975; A new antigen-antibody system. Clinical significance in long-term carriers of hepatitis B surface antigen. Journal of the American Medical Association 231:356–359
    [Google Scholar]
15. Moodie J., Stannard L. M., Kipps A. 1974; Dane complexes in hepatitis B antigen. Journal of General Virology 24:375–379
    [Google Scholar]
16. Moritsugu Y., Gold J. W. M., Wagner J.-A., Dodd R. Y., Purcell R. H. 1975; Hepatitis B core antigen. Detection of antibody by radioimmunoprecipitation. Journal of Immunology 114:1792–1798
    [Google Scholar]
17. Neurath A. R., Korcek L., Prince A. M., Lippin A., Chen M. 1975a; Thyroxine binding by hepatitis B surface antigen. Journal of Infectious Diseases 131:172–176
    [Google Scholar]
18. Neurath A. R., Lerman S., Chen M., Prince A. M. 1975b; Hydrophobic chromatography of hepatitis B surface antigen on 1, 9-diaminononane or 1, 10-diaminodecane linked to agarose. Journal of General Virology 28:251–254
    [Google Scholar]
19. Neurath A. R., Prince A. M., Lippin A. 1974; Hepatitis B antigen: antigenic sites related to human serum proteins revealed by affinity chromatography. Proceedings of the National Academy of Sciences of the United States of America 71:2663–2667
    [Google Scholar]
20. Nielsen J. O., Dietrichson O., Juhl E. 1974; Incidence and meaning of the ‘e’ determinant among hepatitis B antigen positive patients with acute and chronic liver diseases. Lancet i:913–915
    [Google Scholar]
21. Nielsen J. O., Nielsen M. H., Elling P. 1973; Differential distribution of Australia-antigen associated particles in patients with liver diseases and normal carriers. New England Journal of Medicine 288:484–487
    [Google Scholar]
22. Prince A. M., Trepo C. 1975; Lack of homologous immunity to infection by large doses of hepatitis B virus in chimpanzees. Advances in Medical Primatology (in the press)
    [Google Scholar]
23. Purcell R. H., Gerin J. L. 1975; Hepatitis B subunit vaccine: A preliminary report of safety and efficacy tests in chimpanzees. American Journal of Medical Sciences 270:395–399
    [Google Scholar]
24. Purcell R. H., Gerin J. L., Almeida J. B., Holland P. V. 1974; Radioimmunoassay for the detection of the core of the Dane particle and antibody to it. Intervirology 2:231–243
    [Google Scholar]
25. Trepo C. 1975 In General Discussion at The Symposium on Viral Hepatitis, National Academy of Sciences. March 17–19, 1975 American Journal of Medical Sciences 270:206
    [Google Scholar]
26. Woolf I. L., Tones D. M., Tapp E., Dymock I. W. 1975; Electron microscopy of serum of healthy hepatitis B antigen carriers. Journal of Clinical Pathology 28:260–262
    [Google Scholar]
27. Yamada G. 1974; Electron microscopic observations on hepatitis B antigen-associated particles in the sera of patients with various liver diseases. Acta Medica Okayama 28:27–45
    [Google Scholar]